Home
Diseases
Influenza
Clinical Trials

Clinical Trials Related to Influenza

Related studies linked through entity extraction aliases.

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older

Status: COMPLETED
Phase: PHASE3

Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years

Status: COMPLETED
Phase: PHASE4

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK2321138A) Manufactured Using a New Process in Adults and Children

Status: COMPLETED
Phase: PHASE3

H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo...

Status: COMPLETED
Phase: PHASE1

Influenza Immunization in Adults Over Age 75

Status: RECRUITING
Phase: NA

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A in Adults 18 to 60 Years of Age

Status: WITHDRAWN
Phase: PHASE1

Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics

Status: COMPLETED
Phase: NA

Impact of Influenza Vaccination in Pregnancy Video Education

Status: COMPLETED
Phase: NA

Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults

Status: COMPLETED
Phase: PHASE1

Fluarix/ FluLaval/ Fluarix Quadrivalent/ FluLaval Quadrivalent Vaccine Pregnancy Registry

Status: COMPLETED
Phase: N/A

Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)

Status: COMPLETED
Phase: PHASE4

Post-License Safety Evaluation of Influenza Virus Vaccine

Status: COMPLETED
Phase: N/A

The Influence of Chronic CMV Infection on Influenza Vaccine Responses

Status: COMPLETED
Phase: PHASE4

B-cell Immunity to Influenza (SLVP017)- Year 1, 2009

Status: COMPLETED
Phase: PHASE4

A Post-marketing Safety Study of Inactivated, Split-virion Influenza Vaccine in Subjects Aged 3 Years and Older

Status: COMPLETED
Phase: N/A

Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above

Status: COMPLETED
Phase: PHASE1

Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs

Status: COMPLETED
Phase: N/A

A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)

Status: COMPLETED
Phase: PHASE1/PHASE2

A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects

Status: COMPLETED
Phase: PHASE1/PHASE2

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

Status: COMPLETED
Phase: PHASE3